v3.26.1
Organization and Basis of Presentation (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
May 27, 2022
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Organization and Basis of Presentation [Line Items]                      
Shares, Issued 35,261,871                    
Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 18,144,112                    
Cash   $ 196,522           $ 196,522      
Retained Earnings (Accumulated Deficit)   29,755,621           29,755,621   $ 26,193,306  
Cash provided by (used in) operating activity, including discontinued operation               898,957 $ 399,939    
Stockholders’ deficit   (2,714,316) $ (891,095) $ (1,059,320) $ (1,596,643) $ (2,076,864) $ (1,840,381) (2,714,316) (1,596,643) $ (1,312,382) $ (1,714,130)
Working capital deficit   $ 2,551,952           $ 2,551,952      
Common stock, shares issued   36,410,120           36,410,120   30,175,763  
Common stock, shares outstanding   36,410,120           36,410,120   30,175,763  
Net loss   $ 2,556,468 $ 429,567 $ 576,280 $ 397,779 $ 298,983 $ 5,001,251 $ 3,562,315 $ 5,698,013    
Legacy Genvor [Member]                      
Organization and Basis of Presentation [Line Items]                      
Common stock, shares issued 55,261,871                    
Common stock, shares outstanding 55,261,871